The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
New insights into pre-BCR and BCR signalling with relevance to B cell malignancies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stromal Gene Signatures in Large-B-Cell Lymphomas
Lenz, G., Wright, G., Dave, S. S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802885 · Cited by 1,808
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
Davis, R. E., Ngo, V. N., Lenz, G., Tolar, P., Young, R. M., Romesser, P. B., Kohlhammer, H., Lamy, L., Zhao, H., Yang, Y., et al. (2010) · Nature · doi:10.1038/nature08638 · Cited by 1,643
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M., et al. (2011) · Nature · doi:10.1038/nature10351 · Cited by 1,614
Oncogenically active MYD88 mutations in human lymphoma
Ngo, V. N., Young, R. M., Schmitz, R., Jhavar, S., Xiao, W., Lim, K.-H., Kohlhammer, H., Xu, W., Yang, Y., Zhao, H., et al. (2011) · Nature · doi:10.1038/nature09671 · Cited by 1,512
Lam, K.-P., Kühn, R., & Rajewsky, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80373-6 · Cited by 1,108
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
Lenz, G., Wright, G. W., Emre, N. C. T., Kohlhammer, H., Dave, S. S., Davis, R. E., Carty, S., Lam, L. T., Shaffer, A. L., Xiao, W., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804295105 · Cited by 995
Mechanisms of B-cell lymphoma pathogenesis
Küppers, R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1589 · Cited by 965
Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice
Okkenhaug, K., Bilancio, A., Farjot, G., Priddle, H., Sancho, S., Peskett, E., Pearce, W., Meek, S. E., Salpekar, A., Waterfield, M. D., et al. (2002) · Science · doi:10.1126/science.1073560 · Cited by 946
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
Schmitz, R., Young, R. M., Ceribelli, M., Jhavar, S., Xiao, W., Zhang, M., Wright, G., Shaffer, A. L., Hodson, D. J., Buras, E., et al. (2012) · Nature · doi:10.1038/nature11378 · Cited by 924
Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma
Lenz, G., Davis, R. E., Ngo, V. N., Lam, L., George, T. C., Wright, G. W., Dave, S. S., Zhao, H., Xu, W., Rosenwald, A., et al. (2008) · Science · doi:10.1126/science.1153629 · Cited by 867
Friedberg, J. W., Sharman, J., Sweetenham, J., Johnston, P. B., Vose, J. M., LaCasce, A., Schaefer-Cutillo, J., De Vos, S., Sinha, R., Leonard, J. P., et al. (2010) · Blood · doi:10.1182/blood-2009-08-236471 · Cited by 747
PI3 Kinase Signals BCR-Dependent Mature B Cell Survival
Srinivasan, L., Sasaki, Y., Calado, D. P., Zhang, B., Paik, J. H., DePinho, R. A., Kutok, J. L., Kearney, J. F., Otipoby, K. L., & Rajewsky, K. (2009) · Cell · doi:10.1016/j.cell.2009.08.041 · Cited by 661
A loss-of-function RNA interference screen for molecular targets in cancer
Ngo, V. N., Davis, R. E., Lamy, L., Yu, X., Zhao, H., Lenz, G., Lam, L. T., Dave, S., Yang, L., Powell, J., et al. (2006) · Nature · doi:10.1038/nature04687 · Cited by 605
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells
Messmer, B. T., Messmer, D., Allen, S. L., Kolitz, J. E., Kudalkar, P., Cesar, D., Murphy, E. J., Koduru, P., Ferrarini, M., Zupo, S., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523409 · Cited by 599
Survival of Resting Mature B Lymphocytes Depends on BCR Signaling via the Igα/β Heterodimer
Kraus, M., Alimzhanov, M. B., Rajewsky, N., & Rajewsky, K. (2004) · Cell · doi:10.1016/j.cell.2004.05.014 · Cited by 572
Frequent inactivation of A20 in B-cell lymphomas
Kato, M., Sanada, M., Kato, I., Sato, Y., Takita, J., Takeuchi, K., Niwa, A., Chen, Y., Nakazaki, K., Nomoto, J., et al. (2009) · Nature · doi:10.1038/nature07969 · Cited by 555
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
Minden, M. D.-V., Übelhart, R., Schneider, D., Wossning, T., Bach, M. P., Buchner, M., Hofmann, D., Surova, E., Follo, M., Köhler, F., et al. (2012) · Nature · doi:10.1038/nature11309 · Cited by 504
The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry
Dominguez-Sola, D., Victora, G. D., Ying, C. Y., Phan, R. T., Saito, M., Nussenzweig, M. C., & Dalla-Favera, R. (2012) · Nature Immunology · doi:10.1038/ni.2428 · Cited by 490
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
Schmitz, R., Hansmann, M.-L., Bohle, V., Martin-Subero, J. I., Hartmann, S., Mechtersheimer, G., Klapper, W., Vater, I., Giefing, M., Gesk, S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090528 · Cited by 481
AID Is Required for the Chromosomal Breaks in c-myc that Lead to c-myc/IgH Translocations
Robbiani, D. F., Bothmer, A., Callen, E., Reina-San-Martin, B., Dorsett, Y., Difilippantonio, S., Bolland, D. J., Chen, H. T., Corcoran, A. E., Nussenzweig, A., et al. (2008) · Cell · doi:10.1016/j.cell.2008.09.062 · Cited by 467
The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers
Calado, D. P., Sasaki, Y., Godinho, S. A., Pellerin, A., Köchert, K., Sleckman, B. P., de Alborán, I. M., Janz, M., Rodig, S., & Rajewsky, K. (2012) · Nature Immunology · doi:10.1038/ni.2418 · Cited by 447
Clayton, E., Bardi, G., Bell, S. E., Chantry, D., Downes, C. P., Gray, A., Humphries, L. A., Rawlings, D., Reynolds, H., Vigorito, E., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020805 · Cited by 446
Immunodeficiency in Protein Kinase Cβ-Deficient Mice
Leitges, M., Schmedt, C., Guinamard, R., Davoust, J., Schaal, S., Stabel, S., & Tarakhovsky, A. (1996) · Science · doi:10.1126/science.273.5276.788 · Cited by 439
Map kinase signaling pathways and hematologic malignancies
Platanias, L. C. (2003) · Blood · doi:10.1182/blood-2002-12-3647 · Cited by 432
Chen, L., Widhopf, G., Huynh, L., Rassenti, L., Rai, K. R., Weiss, A., & Kipps, T. J. (2002) · Blood · doi:10.1182/blood-2002-06-1683 · Cited by 426
B-cell receptor signaling in chronic lymphocytic leukemia
Stevenson, F. K., Krysov, S., Davies, A. J., Steele, A. J., & Packham, G. (2011) · Blood · doi:10.1182/blood-2011-06-338855 · Cited by 390
Regulation of NF-κB-Dependent Lymphocyte Activation and Development by Paracaspase
Ruefli-Brasse, A. A., French, D. M., & Dixit, V. M. (2003) · Science · doi:10.1126/science.1090769 · Cited by 379
Rossi, D., Trifonov, V., Fangazio, M., Bruscaggin, A., Rasi, S., Spina, V., Monti, S., Vaisitti, T., Arruga, F., Famà, R., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120904 · Cited by 379
Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling
Herzog, S., Reth, M., & Jumaa, H. (2009) · Nature Reviews Immunology · doi:10.1038/nri2491 · Cited by 357
Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation
Dengler, H. S., Baracho, G. V., Omori, S. A., Bruckner, S., Arden, K. C., Castrillon, D. H., DePinho, R. A., & Rickert, R. C. (2008) · Nature Immunology · doi:10.1038/ni.1667 · Cited by 354
Self-citationPhosphorylation of the CARMA1 Linker Controls NF-κB Activation
Sommer, K., Guo, B., Pomerantz, J. L., Bandaranayake, A. D., Moreno-García, M. E., Ovechkina, Y. L., & Rawlings, D. J. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.014 · Cited by 351
Integration of B cell responses through Toll-like receptors and antigen receptors
Rawlings, D. J., Schwartz, M. A., Jackson, S. W., & Meyer-Bahlburg, A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3190 · Cited by 339
PKC-β controls IκB kinase lipid raft recruitment and activation in response to BCR signaling
Su, T. T., Guo, B., Kawakami, Y., Sommer, K., Chae, K., Humphries, L. A., Kato, R. M., Kang, S., Patrone, L., Wall, R., et al. (2002) · Nature Immunology · doi:10.1038/ni823 · Cited by 322
Chen, L., Monti, S., Juszczynski, P., Daley, J., Chen, W., Witzig, T. E., Habermann, T. M., Kutok, J. L., & Shipp, M. A. (2008) · Blood · doi:10.1182/blood-2007-07-100115 · Cited by 316
ITAM-mediated tonic signalling through pre-BCR and BCR complexes
Monroe, J. G. (2006) · Nature Reviews Immunology · doi:10.1038/nri1808 · Cited by 313
Jun, J. E., Wilson, L. E., Vinuesa, C. G., Lesage, S., Blery, M., Miosge, L. A., Cook, M. C., Kucharska, E. M., Hara, H., Penninger, J. M., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00141-9 · Cited by 300
Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis
Sander, S., Calado, D. P., Srinivasan, L., Köchert, K., Zhang, B., Rosolowski, M., Rodig, S. J., Holzmann, K., Stilgenbauer, S., Siebert, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.012 · Cited by 300
Integrin signalling adaptors: not only figurants in the cancer story
Cabodi, S., del Pilar Camacho-Leal, M., Di Stefano, P., & Defilippi, P. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2967 · Cited by 291
Amin, R. H., & Schlissel, M. S. (2008) · Nature Immunology · doi:10.1038/ni.1612 · Cited by 286
Signaling by the tumor necrosis factor receptor superfamily in B‐cell biology and disease
Rickert, R. C., Jellusova, J., & Miletic, A. V. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01067.x · Cited by 285
Self-citationCellular origin and pathophysiology of chronic lymphocytic leukemia
Seifert, M., Sellmann, L., Bloehdorn, J., Wein, F., Stilgenbauer, S., Dürig, J., & Küppers, R. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120833 · Cited by 283
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma
Rudelius, M., Pittaluga, S., Nishizuka, S., Pham, T. H.-T., Fend, F., Jaffe, E. S., Quintanilla-Martinez, L., & Raffeld, M. (2006) · Blood · doi:10.1182/blood-2006-04-015586 · Cited by 277
Zhang, J., Mullighan, C. G., Harvey, R. C., Wu, G., Chen, X., Edmonson, M., Buetow, K. H., Carroll, W. L., Chen, I.-M., Devidas, M., et al. (2011) · Blood · doi:10.1182/blood-2011-03-341412 · Cited by 277
The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents Autoimmunity
Tavares, R. M., Turer, E. E., Liu, C. L., Advincula, R., Scapini, P., Rhee, L., Barrera, J., Lowell, C. A., Utz, P. J., Malynn, B. A., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.07.017 · Cited by 271
Kang, S., Denley, A., Vanhaesebroeck, B., & Vogt, P. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510772103 · Cited by 267
Contri, A., Brunati, A. M., Trentin, L., Cabrelle, A., Miorin, M., Cesaro, L., Pinna, L. A., Zambello, R., Semenzato, G., & Donella-Deana, A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522094 · Cited by 261
Pao, L. I., Lam, K.-P., Henderson, J. M., Kutok, J. L., Alimzhanov, M., Nitschke, L., Thomas, M. L., Neel, B. G., & Rajewsky, K. (2007) · Immunity · doi:10.1016/j.immuni.2007.04.016 · Cited by 258
Novak, U., Rinaldi, A., Kwee, I., Nandula, S. V., Rancoita, P. M. V., Compagno, M., Cerri, M., Rossi, D., Murty, V. V., Zucca, E., et al. (2009) · Blood · doi:10.1182/blood-2008-08-174110 · Cited by 246
Petlickovski, A., Laurenti, L., Li, X., Marietti, S., Chiusolo, P., Sica, S., Leone, G., & Efremov, D. G. (2005) · Blood · doi:10.1182/blood-2004-07-2669 · Cited by 245
Clonal evolution of a follicular lymphoma: evidence for antigen selection.
Bahler, D. W., & Levy, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6770 · Cited by 241
The B Cell Antigen Receptor Controls Integrin Activity through Btk and PLCγ2
Spaargaren, M., Beuling, E. A., Rurup, M. L., Meijer, H. P., Klok, M. D., Middendorp, S., Hendriks, R. W., & Pals, S. T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20011866 · Cited by 228
Tang, T. T.-L., Dowbenko, D., Jackson, A., Toney, L., Lewin, D. A., Dent, A. L., & Lasky, L. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110901200 · Cited by 223
Bende, R. J., Aarts, W. M., Riedl, R. G., de Jong, D., Pals, S. T., & van Noesel, C. J. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050068 · Cited by 221
Corfe, S. A., & Paige, C. J. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.02.001 · Cited by 211
Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas.
Oka, T., Ouchida, M., Koyama, M., Ogama, Y., Takada, S., Nakatani, Y., Tanaka, T., Yoshino, T., Hayashi, K., Ohara, N., et al. (2002) · PubMed · Cited by 208
The BAFF Receptor Transduces Survival Signals by Co-opting the B Cell Receptor Signaling Pathway
Schweighoffer, E., Vanes, L., Nys, J., Cantrell, D., McCleary, S., Smithers, N., & Tybulewicz, V. L. J. (2013) · Immunity · doi:10.1016/j.immuni.2012.11.015 · Cited by 208
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition
Duy, C., Hurtz, C., Shojaee, S., Cerchietti, L., Geng, H., Swaminathan, S., Klemm, L., Kweon, S.-M., Nahar, R., Braig, M., et al. (2011) · Nature · doi:10.1038/nature09883 · Cited by 204
Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma
Hailfinger, S., Lenz, G., Ngo, V., Posvitz-Fejfar, A., Rebeaud, F., Guzzardi, M., Penas, E.-M. M., Dierlamm, J., Chan, W. C., Staudt, L. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907511106 · Cited by 204
Ferch, U., Kloo, B., Gewies, A., Pfänder, V., Düwel, M., Peschel, C., Krappmann, D., & Ruland, J. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091167 · Cited by 203
Gobessi, S., Laurenti, L., Longo, P. G., Carsetti, L., Berno, V, Sica, S., Leone, G., & Efremov, D. G. (2009) · Leukemia · doi:10.1038/leu.2008.346 · Cited by 200
IKKβ Is Required for Peripheral B Cell Survival and Proliferation
Li, Z.-W., Omori, S. A., Labuda, T., Karin, M., & Rickert, R. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4630 · Cited by 192
Self-citationThe tipping points in the initiation of B cell signalling: how small changes make big differences
Pierce, S. K., & Liu, W. (2010) · Nature Reviews Immunology · doi:10.1038/nri2853 · Cited by 192
Lyn Tyrosine KinaseAccentuating the Positive and the Negative
XU, Y., HARDER, K., HUNTINGTON, N., HIBBS, M., & TARLINTON, D. (2005) · Immunity · doi:10.1016/s1074-7613(04)00381-4 · Cited by 188
The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion
Flemming, A., Brummer, T., Reth, M., & Jumaa, H. (2003) · Nature Immunology · doi:10.1038/ni862 · Cited by 184
Buchner, M., Fuchs, S., Prinz, G., Pfeifer, D., Bartholomé, K., Burger, M., Chevalier, N., Vallat, L., Timmer, J., Gribben, J. G., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4252 · Cited by 184
The ARF tumor suppressor: Structure, functions and status in cancer
Ozenne, P., Eymin, B., Brambilla, E., & Gazzeri, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25511 · Cited by 183
IκB Kinase Signaling Is Essential for Maintenance of Mature B Cells
Pasparakis, M., Schmidt-Supprian, M., & Rajewsky, K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020907 · Cited by 182
PTEN Gene Alterations in Lymphoid Neoplasms
Sakai, A., Thieblemont, C., Wellmann, A., Jaffe, E. S., & Raffeld, M. (1998) · Blood · doi:10.1182/blood.v92.9.3410 · Cited by 174
FOXO1 is a tumor suppressor in classical Hodgkin lymphoma
Xie, L., Ushmorov, A., Leithäuser, F., Guan, H., Steidl, C., Färbinger, J., Pelzer, C., Vogel, M. J., Maier, H. J., Gascoyne, R. D., et al. (2012) · Blood · doi:10.1182/blood-2011-09-381905 · Cited by 171
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765)
Burger, J. A., & Buggy, J. J. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.777837 · Cited by 170
The nonimmunoglobulin portion of λ5 mediates cell-autonomous pre-B cell receptor signaling
Ohnishi, K., & Melchers, F. (2003) · Nature Immunology · doi:10.1038/ni959 · Cited by 169
Control of B cell development by Ras‐mediated activation of Raf
Iritani, B. M., Forbush, K. A., Farrar, M. A., & Perlmutter, R. M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.7019 · Cited by 169
Yasuda, T., Sanjo, H., Pagès, G., Kawano, Y., Karasuyama, H., Pouysségur, J., Ogata, M., & Kurosaki, T. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.015 · Cited by 168
Takizawa, M., Tolarová, H., Li, Z., Dubois, W., Lim, S. E., Callén, E., Franco, S., Mosaico, M., Feigenbaum, L., Alt, F. W., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081007 · Cited by 168
O'Neill, S. K., Getahun, A., Gauld, S. B., Merrell, K. T., Tamir, I., Smith, M. J., Dal Porto, J. M., Li, Q.-Z., & Cambier, J. C. (2011) · Immunity · doi:10.1016/j.immuni.2011.10.011 · Cited by 165
Ochiai, K., Maienschein-Cline, M., Mandal, M., Triggs, J. R., Bertolino, E., Sciammas, R., Dinner, A. R., Clark, M. R., & Singh, H. (2012) · Nature Immunology · doi:10.1038/ni.2210 · Cited by 165
FoxO3a and BCR-ABL Regulate cyclin D2 Transcription through a STAT5/BCL6-Dependent Mechanism
Fernández de Mattos, S., Essafi, A., Soeiro, I., Pietersen, A. M., Birkenkamp, K. U., Edwards, C. S., Martino, A., Nelson, B. H., Francis, J. M., Jones, M. C., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.10058-10071.2004 · Cited by 161
Arana, E., Vehlow, A., Harwood, N. E., Vigorito, E., Henderson, R., Turner, M., Tybulewicz, V. L. J., & Batista, F. D. (2008) · Immunity · doi:10.1016/j.immuni.2007.12.003 · Cited by 156
Newton, K., & Dixit, V. M. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00458-5 · Cited by 155
Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development
Sagaert, X., Cutsem, E. V., Hertogh, G. D., Geboes, K., & Tousseyn, T. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.58 · Cited by 155
SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway
Herzog, S., Hug, E., Meixlsperger, S., Paik, J.-H., DePinho, R. A., Reth, M. G., & Jumaa, H. (2008) · Nature Immunology · doi:10.1038/ni.1616 · Cited by 154
RasGRP1 and RasGRP3 Regulate B Cell Proliferation by Facilitating B Cell Receptor-Ras Signaling
Coughlin, J. J., Stang, S. L., Dower, N. A., & Stone, J. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7179 · Cited by 154
Horikawa, K., Martin, S., Pogue, S., Silver, K. L., Peng, K.-M., Takatsu, K., & Goodnow, C. (2007) · Journal of Experimental Medicine · doi:10.1084/jem.20061923 · Cited by 152
Kloo, B., Nagel, D., Pfeifer, M., Grau, M., Düwel, M., Vincendeau, M., Dörken, B., Lenz, P., Lenz, G., & Krappmann, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008969108 · Cited by 148
Irish, J. M., Czerwinski, D. K., Nolan, G. P., & Levy, R. (2006) · Blood · doi:10.1182/blood-2006-02-003921 · Cited by 148
Hoellenriegel, J., Coffey, G., Sinha, U., Pandey, A., Sivina, M., Ferrajoli, A., Ravandi, F., Wierda, W. G., O'Brien, S. M., Keating, M. J., et al. (2012) · Leukemia · doi:10.1038/leu.2012.24 · Cited by 145
Radcliffe, C. M., Arnold, J. N., Suter, D. M., Wormald, M. R., Harvey, D. J., Royle, L., Mimura, Y., Kimura, Y., Sim, R. B., Inogés, S., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602690200 · Cited by 145
BCL6 is critical for the development of a diverse primary B cell repertoire
Duy, C., Yu, J. J., Nahar, R. R., Swaminathan, S., Kweon, S.-M., Polo, J. M., Valls, E., Klemm, L., Shojaee, S., Cerchietti, L. C. A., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091299 · Cited by 144
Waisman, A., Kraus, M., Seagal, J., Ghosh, S., Melamed, D., Song, J., Sasaki, Y., Classen, S., Lutz, C., Brombacher, F., et al. (2007) · Journal of Experimental Medicine · doi:10.1084/jem.20062024 · Cited by 144
PI3Kδ Inhibitors in Cancer: Rationale and Serendipity Merge in the Clinic
Fruman, D. A., & Rommel, C. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0249 · Cited by 141
Malignant pirates of the immune system
Rui, L., Schmitz, R., Ceribelli, M., & Staudt, L. M. (2011) · Nature Immunology · doi:10.1038/ni.2094 · Cited by 140
Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia
Jumaa, H., Bossaller, L., Portugal, K., Storch, B., Lotz, M., Flemming, A., Schrappe, M., Postila, V., Riikonen, P. V., Pelkonen, J., et al. (2003) · Nature · doi:10.1038/nature01608 · Cited by 140
NF‐κB function in B lymphocytes
Kaileh, M., & Sen, R. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01106.x · Cited by 138
Liu, W., Meckel, T., Tolar, P., Sohn, H. W., & Pierce, S. K. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.006 · Cited by 136
FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of ArfPreprint
Bouchard, C., Lee, S., Paulus-Hock, V., Loddenkemper, C., Eilers, M., & Schmitt, C. A. (2007) · Genes & Development · doi:10.1101/gad.453107 · Cited by 136
ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia
Chen, L., Huynh, L., Apgar, J., Tang, L., Rassenti, L., Weiss, A., & Kipps, T. J. (2008) · Blood · doi:10.1182/blood-2006-12-062265 · Cited by 131
Inhibition of the MEK/ERK Signaling Pathway Blocks a Subset of B Cell Responses to Antigen
Richards, J. D., Davé, S. H., Chou, C.-H. G., Mamchak, A. A., & DeFranco, A. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3855 · Cited by 130
Integration of DAG signaling systems mediated by PKC-dependent phosphorylation of RasGRP3
Teixeira, C., Stang, S. L., Zheng, Y., Beswick, N. S., & Stone, J. C. (2003) · Blood · doi:10.1182/blood-2002-11-3621 · Cited by 127
BLNK suppresses pre–B-cell leukemogenesis through inhibition of JAK3
Nakayama, J., Yamamoto, M., Hayashi, K., Satoh, H., Bundo, K., Kubo, M., Goitsuka, R., Farrar, M. A., & Kitamura, D. (2008) · Blood · doi:10.1182/blood-2008-07-166355 · Cited by 120
Xu, D., Liu, X., Yu, W., Meyerson, H. J., Guo, C., Gerson, S. L., & Qu, C. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110450 · Cited by 120
Cutting Edge: Constitutive B Cell Receptor Signaling Is Critical for Basal Growth of B Lymphoma
Gururajan, M., JENNINGS, C. D., & Bondada, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.5715 · Cited by 118
Baracho, G. V., Miletic, A. V., Omori, S., Cato, M. H., & RC, R. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.01.001 · Cited by 116
Kersseboom, R., Middendorp, S., Dingjan, G. M., Dahlenborg, K., Reth, M. G., Jumaa, H., & Hendriks, R. W. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030615 · Cited by 115
Oh-hora, M., Johmura, S., Hashimoto, A., Hikida, M., & Kurosaki, T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031547 · Cited by 113
CD19 is a major B cell receptor–independent activator of MYC-driven B-lymphomagenesis
Chung, E. Y., Psathas, J. N., Yu, D., Li, Y., Weiss, M. J., & Thomas‐Tikhonenko, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci45851 · Cited by 112
O’Reilly, L. A., Kruse, E., Puthalakath, H., Kelly, P. N., Kaufmann, T., Huang, D. C. S., & Strasser, A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803853 · Cited by 110
Alfarano, A., Indraccolo, S., Circosta, P., Minuzzo, S. A., Vallario, A., Zamarchi, R., Fregonese, A., Calderazzo, F., Faldella, A., Aragno, M., et al. (1999) · Blood · doi:10.1182/blood.v93.7.2327 · Cited by 109
Krysov, S. V., Dias, S., Paterson, A. R., Mockridge, C. I., Potter, K. N., Smith, K.-A., Ashton‐Key, M., Stevenson, F. K., & Packham, G. (2011) · Blood · doi:10.1182/blood-2011-07-370403 · Cited by 104
Yan, Q., Huang, Y., Watkins, J. A., Kocialkowski, S., Zeng, N., Hamoudi, R., Isaacson, P. G., de Leval, L., Wotherspoon, A. C., & Du, M. (2011) · Haematologica · doi:10.3324/haematol.2011.054080 · Cited by 99
Ruminy, P., Etancelin, P., Couronné, L., Parmentier, F., Rainville, V., Mareschal, S., Bohers, É., Burgot, C., Cornic, M., Bertrand, P., et al. (2011) · Leukemia · doi:10.1038/leu.2010.302 · Cited by 93
Refaeli, Y., Young, R. M., Turner, B. C., Duda, J., Field, K. A., & Bishop, J. M. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060152 · Cited by 92
Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases
Miletic, A. V., Anzelon-Mills, A. N., Mills, D. M., Omori, S. A., Pedersen, I. M., Shin, D., Ravetch, J. V., Bolland, S. M., Morse, H. C., & Rickert, R. C. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091962 · Cited by 88
Self-citationLamason, R. L., McCully, R. R., Lew, S. M., & Pomerantz, J. L. (2010) · Biochemistry · doi:10.1021/bi101052d · Cited by 86
Bende, R. J., van Maldegem, F., & van Noesel, C. J. M. (2009) · Haematologica · doi:10.3324/haematol.2009.005983 · Cited by 85
Wossning, T., Herzog, S., Köhler, F., Meixlsperger, S., Kulathu, Y., Mittler, G., Abe, A., Fuchs, U., Borkhardt, A., & Jumaa, H. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060967 · Cited by 83
Gazumyan, A., Reichlin, A., & Nussenzweig, M. C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060221 · Cited by 83
Cyclin D3 Is Selectively Required for Proliferative Expansion of Germinal Center B Cells
Cato, M. H., Chintalapati, S. K., Yau, I. W., Omori, S. A., & Rickert, R. C. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00650-10 · Cited by 82
Self-citationFerch, U., Büschenfelde, C. M. Z., Gewies, A., Wegener, E., Rauser, S., Peschel, C., Krappmann, D., & Ruland, J. (2007) · Nature Immunology · doi:10.1038/ni1493 · Cited by 81
Shaw, A. C., Swat, W., Ferrini, R., Davidson, L., & Alt, F. W. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.1.123 · Cited by 75
Regulation of integrin activation through the B-cell receptor
Arana, E., Harwood, N. E., & Batista, F. D. (2008) · Journal of Cell Science · doi:10.1242/jcs.017905 · Cited by 75
Targeting the microenvironment in chronic lymphocytic leukemia is changing the therapeutic landscape
Burger, J. A. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283589950 · Cited by 73
Peters, S. B. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-386469-7.00006-2 · Cited by 71
Requirement for cyclin D3 in germinal center formation and function
Peled, J. U., Yu, J. J., Jeganathan, V., Bi, E., Ding, B. B., Krupski, M., Shaknovich, R., Siciński, P., Diamond, B., Scharff, M. D., et al. (2010) · Cell Research · doi:10.1038/cr.2010.55 · Cited by 67
Mechanisms and clinical significance of BIM phosphorylation in chronic lymphocytic leukemia
Paterson, A. R., Mockridge, C. I., Adams, J. E., Krysov, S. V., Potter, K. N., Duncombe, A. S., Cook, S. J., Stevenson, F. K., & Packham, G. (2011) · Blood · doi:10.1182/blood-2011-07-367417 · Cited by 66
Cytogenetic and Molecular Predictors of Outcome in Acute Lymphocytic Leukemia: Recent Developments
Iacobucci, I., Papayannidis, C., Lonetti, A., Ferrari, A., Baccarani, M., & Martinelli, G. (2012) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-012-0122-5 · Cited by 65
Frank, M. J., Dawson, D. W., Bensinger, S. J., Hong, J. S., Knosp, W. M., Xu, L., Balatoni, C. E., Allen, E. L., Shen, R. R., Bar‐Sagi, D., et al. (2009) · Blood · doi:10.1182/blood-2008-05-156943 · Cited by 59
Surface IgM of CLL cells displays unusual glycans indicative of engagement of antigen in vivo
Krysov, S. V., Potter, K. N., Mockridge, C. I., Coelho, V., Wheatley, I., Packham, G., & Stevenson, F. K. (2010) · Blood · doi:10.1182/blood-2009-12-254847 · Cited by 59
Klein, F., Feldhahn, N., Harder, L., Wang, H., Wartenberg, M., Hofmann, W., Wernet, P., Siebert, R., & Müschen, M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031637 · Cited by 57
New Btk inhibitor holds promise
Hendriks, R. W. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.502 · Cited by 55
Visualizing a role for the actin cytoskeleton in the regulation of B‐cell activation
Batista, F. D., Treanor, B., & Harwood, N. E. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00943.x · Cited by 52
Genome-Wide Detection of Genes Targeted by Non-Ig Somatic Hypermutation in Lymphoma
Jiang, Y., Soong, T. D., Wang, L., Melnick, A. M., & Elemento, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040332 · Cited by 52
Bhalla, S., Evens, A. M., Dai, B., Prachand, S., Gordon, L. I., & Gartenhaus, R. B. (2011) · Blood · doi:10.1182/blood-2011-03-340109 · Cited by 51
The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis
Cragg, M. S., Chan, H. T. C., Fox, M. D., Tutt, A., Smith, A., Oscier, D. G., Hamblin, T. J., & Glennie, M. J. (2002) · Blood · doi:10.1182/blood.v100.9.3068 · Cited by 51
Molecular Characterization of Immunoglobulin Gene Rearrangements in Diffuse Large B-Cell Lymphoma
Sebastián, E., Alcoceba, M., Balanzategui, A., Marín, L., Montes‐Moreno, S., Flores, T., González, D., Sarasquete, M. E., Chillón, C., Puig, N., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.07.028 · Cited by 51
Mizuno, T., & Rothstein, T. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6062 · Cited by 46
Mozzetta, C., Consalvi, S., Saccone, V., Forcales, S. V., Puri, P., & Palacios, D. (2011) · Cell Cycle · doi:10.4161/cc.10.2.14441 · Cited by 46
Dye, J. R., Palvanov, A., Guo, B., & Rothstein, T. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.229 · Cited by 35
Guo, B., & Rothstein, T. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5375 · Cited by 31
BLNK Binds Active H-Ras to Promote B Cell Receptor-mediated Capping and ERK Activation
Imamura, Y., Oda, A., Katahira, T., Bundo, K., Pike, K. A., Ratcliffe, M. J. H., & Kitamura, D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809051200 · Cited by 30
Malt1 and cIAP2–Malt1 as effectors of NF-κB activation: Kissing cousins or distant relatives?
Kingeter, L. M., & Schaefer, B. C. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.09.033 · Cited by 30
Epigenetic inactivation of the ERK inhibitor Spry2 in B-cell diffuse lymphomas
Sánchez, A., Setién, F., Martinez, N., et al. (2008) · Oncogene · doi:10.1038/onc.2008.129 · Cited by 28
Schrader, A., Meyer, K., von Bonin, F., Vockerodt, M., Walther, N., Hand, E., Ulrich, A., Matulewicz, K., Lenze, D., Hummel, M., et al. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-43 · Cited by 21
Cited by
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
PI3K signalling in inflammation
Hawkins, P. T., & Stephens, L. R. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.12.006 · Cited by 541
Mechanisms of central tolerance for B cells
Nemazee, D. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.19 · Cited by 539
Targeting B cell receptor signalling in cancer: preclinical and clinical advances
Burger, J. A., & Wiestner, A. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.121 · Cited by 431
Gsk3 is a metabolic checkpoint regulator in B cells
Jellusova, J., Cato, M. H., Apgar, J. R., Ramezani-Rad, P., Leung, C. R., Chen, C., Richardson, A. D., Conner, E. M., Benschop, R. J., Woodgett, J. R., et al. (2017) · Nature Immunology · doi:10.1038/ni.3664 · Cited by 303
Self-citation
Metadata
- Authors
- Rickert, R. C.
- Venue
- Nature Reviews Immunology
- Published
- 2013-07-25
- Volume
- 13
- Issue
- 8
- Pages
- 578-591
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2034611537
- Cited by
- 288
- References
- 143
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.